𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Buprenorphine/naloxone abuse

✍ Scribed by Bonanni, L.; Bontempo, G.; Borrelli, I.; Bifolchetti, S.; Buongarzone, M. P.; Carlesi, N.; Carolei, A.; Ciccocioppo, F.; Colangelo, U.; Colonna, G.; Desiderio, M.; Ferretti, S.; Fiorelli, L.; D’Alessio, O.; D’Amico, A.; D’Amico, M. C.; De Lucia, R.; Del Re, L.; Di Blasio, F.; Di Giacomo, R.; Di Iorio, A.; Di Santo, E.; Di Giuseppe, M.; Felice, N.; Litterio, P.; Gabriele, A.; Mancino, E.; Manzoli, L.; Maruotti, V.; Mearelli, S.; Molino, G.; Monaco, D.; Nuccetelli, F.; Onofrj, M.; Perfetti, B.; Sacchet, C.; Sensi, F.; Sensi, S.; Sucapane, P.; Taylor, J. P.; Thomas, A.; Viola, P.; Viola, S.; Zito, M.; Zhuzhuni, H.

Book ID
121633495
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2013
Weight
128 KB
Volume
1457
Category
Article
ISSN
0114-9954

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abuse liability of intravenous buprenorp
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers
✍ Sandra D. Comer; Maria A. Sullivan; Suzanne K. Vosburg; Jeanne Manubay; Leslie A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## ABSTRACT **Background** Sublingual buprenorphine is an effective maintenance treatment for opioid dependence, yet intravenous buprenorphine misuse occurs. A buprenorphine/naloxone formulation was developed to mitigate this misuse risk. This randomized, double‐blind, cross‐over study was conducte

Buprenorphine/naloxone
Buprenorphine/naloxone
📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 128 KB
Buprenorphine/naloxone
Buprenorphine/naloxone
✍ Zhang, Yuanxiu; Chen, Mingyang; Hu, Qingmao; Huang, Wenhua 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 127 KB